Hill, Holliday Adds Diovan

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

BOSTON Novartis has shifted creative chores on its Diovan hypertension drug to Hill, Holliday, Connors, Cosmopulos from Deutsch without a review, sources said.

Both agencies are units of the Interpublic Group.

Novartis spent more than $350 million so far this year in measured media across all its brands, but has not advertised Diovan in several years, per Nielsen Monitor-Plus. The drug ranks among the nation’s leading hypertension medications with nearly $1.1 billion in overall sales.

Sources said Diovan ad spending could top $75 million in 2007, with work breaking early next year.

The







AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in